KMDA vs RLMD: stock comparison and AI forecast
Kamada Ltd (KMDA) and Relmada Therapeutics, Inc. (RLMD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
KMDA Kamada Ltd
- Price
- $7.36 -11.2% · 6M
- Market Cap
- $425M
- P/E Ratio
- 11.5x
- Size
- small-cap
- AI Forecast
RLMD Relmada Therapeutics, Inc.
- Price
- $3.84 -48.2% · 6M
- Market Cap
- $410M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- KMDA and RLMD have similar market capitalizations ($425M and $410M).
- Over the last six months KMDA returned -11.2% and RLMD -48.2%.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | KMDA | RLMD |
|---|---|---|
| Market Cap | $425M | $410M |
| P/E Ratio | 11.50x | – |
| P/B Ratio | – | 1.98x |
| EPS | $0.64 | $-1.26 |
| Book Value/Share | – | $1.94 |
| Revenue/Share | $5.48 | – |
Profitability & Margins
| Metric | KMDA | RLMD |
|---|---|---|
| ROE | 11.6% | – |
| ROA | 8.2% | – |
| ROIC | – | -30.8% |
| Gross Margin | 43.0% | – |
| Operating Margin | 15.5% | – |
| Net Margin | 9.8% | – |
| EBT Margin | 13.3% | – |
| Tax Rate | 12.7% | – |
Financial Health
| Metric | KMDA | RLMD |
|---|---|---|
| Current Ratio | – | 29.52x |
| D/E Ratio | – | 0.06x |
| Financial Leverage | 1.41x | 1.06x |
| Interest Coverage | – | -21.3x |
| Working Capital | – | $212M |
Cash Flow
| Metric | KMDA | RLMD |
|---|---|---|
| Operating Cash Flow | $43M | -$46M |
| OCF Growth YoY | -48.2% | – |
Operational Efficiency
| Metric | KMDA | RLMD |
|---|---|---|
| Asset Turnover | 0.84x | – |
| Inventory Turnover | 2.1x | – |
| Fixed Assets Turnover | 7.6x | – |
| Days Inventory | 172 days | – |
| Payables Period | 47 days | – |
Income Statement
| Metric | KMDA | RLMD |
|---|---|---|
| Total Revenue | $316M | – |
| Operating Income | $49M | -$65M |
| Net Income | $31M | – |
| R&D Expense | $23M | $29M |
| Cost of Goods Sold | $180M | – |
Dividend & Shareholder Information
| Metric | KMDA | RLMD |
|---|---|---|
| Shares Outstanding | 58M | 107M |
| EPS Growth | 45.5% | – |
KMDA vs RLMD: stock comparison and AI forecast
Which is bigger, KMDA or RLMD?
KMDA and RLMD have similar market capitalizations ($425M and $410M).
Which stock performed better over the last six months, KMDA or RLMD?
Over the last six months KMDA returned -11.2% and RLMD -48.2%.
Which one does Intratio's AI model rank higher, KMDA or RLMD?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.